All lobbying filings

Fierce Government Relations

Fierce Government Relations filed a Q2 report for Association of Accessible Medicines (Formerly Known as Gpha) on July 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Association of Accessible Medicines (Formerly Known as Gpha) · Trade Organization for Generic Drug Manufacturers and Distributers

As filed: FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA).

All filings by Fierce Government Relations · Everything Association of Accessible Medicines (Formerly Known as Gpha) has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

JAMES WILLIAMS New on this filing

Previously held: Sen. Finance Cmte: Sr Tax/Econ Policy Adv & Tax/IRS Subcmte Staff Dir | Sen. Thune: Sr Policy/Tax/Trade Policy Adv | Sen. Roberts: Dep Leg Dir/Sr Econ Policy Adv | Sen. Hatch: Dep Leg Dir/Sr Policy Adv | Rep. Marchant: Leg Dir/Sr Policy Adv

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

H.R.7410 - American Made Medicine Act; Drug shortages; Generic drugs; Issues around country of origin labeling; S.4327 - Securing America's Drug Supply from Communist China Act; S.2658 - Medication Affordability and Patent Integrity Act; S.3014 - Ensuring Timely Access to Generics Act; S.1414 - Expedited Access to Biosimilars Act; S.1954 - Biosimilar Red Tape Reduction Act; S.3788 - Clear Labels Act; S.4784 - Fiscal Year 2027 National Defense Authorization Act; Supply chain.

Bills named in this filing 8

H.R. 7410
American Made Medicine Act
S. 4327
Securing America’s Drug Supply from Communist China Act
S. 2658
Medication Affordability and Patent Integrity Act
S. 3014
Ensuring Timely Access to Generics Act of 2025
S. 1414
Expedited Access to Biosimilars Act
S. 1954
Biosimilar Red Tape Elimination Act
S. 3788
CLEAR LABELS Act
S. 4784
National Defense Authorization Act for Fiscal Year 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.